drugset / Trial / NCT00209326

A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor

NCT00209326 ↗

Phase 2 Completed 163 enrolled Ferring Pharmaceuticals
RandomizedSingle-groupOpen-labelTreatment

Summary

• To determine the effects of four different single bolus doses of FE200440 administered intravenously on stopping preterm labour compared to placebo in pregnant women with advanced gestational age

Timeline

Start
2003-11
Primary completion
2006-07
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject FE200440 Unknown 0.3 mg Intravenous
Subject FE200440 Unknown 1 mg Intravenous
Subject FE200440 Unknown 3 mg Intravenous
Subject FE200440 Unknown 10 mg Intravenous

Indications

No indication recorded.